Cure My Disease

Don't miss your cure!

 Log in / Sign up

French SOSI-M test under study for kids with developmental disorders

NCT ID NCT07353112

Diagnosis Sponsor: Haute Ecole Ilya Prigogine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to validate a French translation of the SOSI-M test, which measures sensory integration in children. Researchers will film 60 children (30 healthy, 30 with mild to moderate neurodevelopmental disorders) taking the test and compare scores. The goal is to see if the French version works as well as the original and can reliably assess development.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
French translation of the SOSI-M diagnostic test
What this could lead to
If successful, this could provide a reliable French-language tool to assess sensory integration in children with neurodevelopmental disorders.
What could go wrong
This is a small, early-stage validation study (60 participants) that only checks if the test works the same as the original. It does not test any treatment or therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 14 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For the groupe of children with neurodevelopmental disorders : Inclusion criteria * neurodevelopmental disorder (NDD) * speak french and understand instructions in French * and have not been assessed with the SOSI-M in the past 6 months. Exclusion Criteria: * Severe motor/cognitive impairment * uncorrected visual/auditory impairment * cerebral palsy diagnosis For the neurotypical children : Inclusion criteria : \- speak french and understand french instructions Exclusion Criteria: * diagnostic of musculoskeletal condition or neurodevelopmental or neurological condition * health condition that contraindicates taking the SOSI-M

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurodevelopmental disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurodevelopmental disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.